• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Amylin Pharmaceuticals

Amylin Pharmaceuticals

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. ERYTECH Appoints Allene M. Diaz to its Board of Directors

    ERYTECH Appoints Allene M. Diaz to its Board of Directors

  2. Stock Star Rating Performance Update

    As 2005 draws to a close, our performance continues to be solid all around, with some bright spots and a few areas for further improvement. Our contrarian stance on large-cap and energy stocks has weighed on our results recently, but we're still confident that those calls will work out in the end. ...

  3. News and Investing: Stay Cool

    The potential for a key drug in Amylin's pipeline is about to become clearer.

  4. Services Super Sector: Major Themes

    Health-care Sector Although the median health-care stock is slightly overvalued in our opinion, we're very excited by the prospects of the health-care sector. Demographics--especially older, wealthier populations--give many of the firms we cover a strong outlook in 2007 and beyond. We're excited ...

  5. Biotech Investing for the Long Haul

    Three ways to separate long-term winners from stocks that fizzle.

Upcoming Events

©2014 Morningstar Advisor. All right reserved.